Gene organization and evolutionary history
==========================================

The human *hmgr*gene that encodes the single human HMG-CoA reductase is located on chromosome 5, map location 5q13.3-5q14, and is over 24.8 kilobases (kb) long. The 20 exons of the 4,475-nucleotide transcript, which range in size from 27 to 1,813 base-pairs, encode the membrane-anchor domain (exons 2-10), a flexible linker region (exons 10 and 11), and the catalytic domain (exons 11-20) of the resulting 888-residue polypeptide (Figure [1](#F1){ref-type="fig"}).

Genome sequencing has identified *hmgr*genes in organisms from all three domains of life, and over 150 HMGR sequences are recorded in public databases. Higher animals, archaea, and eubacteria have only a single *hmgr*gene, although the lobster has both a soluble and a membrane-associated isozyme, both of which are encoded by a single gene). By contrast, plants, which use both HMGR-dependent and HMGR-independent pathways to synthesize isoprenoids, have multiple HMGR isozymes that appear to have arisen by gene duplication and subsequent sequence divergence \[[@B1]\]. Yeast has two HMGR isozymes derived from two different genes (*hmgr-1*and *hmgr-2*). Comparison of amino-acid sequences and phylogenetic analysis reveals two classes of HMGR, the Class I enzymes of eukaryotes and some archaea and the Class II enzymes of certain eubacteria and archaea, suggesting evolutionary divergence between the two classes (Figure [2](#F2){ref-type="fig"}, Table [1](#T1){ref-type="table"}) \[[@B2],[@B3]\]. The catalytic domain is highly conserved in eukaryotes, but the membrane-anchor domain (consisting of between two and eight membrane-spanning helices) is poorly conserved, and the HMGRs of archaea and of certain eubacteria lack a membrane-anchor domain.

Characteristic structural features
==================================

The HMGRs of different organisms are multimers of a species-specific number of identical monomers. High-resolution crystal structures have been solved for the Class I human enzyme (HMGR~H~) \[[@B4],[@B5]\] and for the Class II enzyme of *Pseudomonas mevalonii*(HMGR~P~) \[[@B6],[@B7]\], including protein forms bound to either the HMG-CoA substrate or the coenzyme (NADH or NADPH) or both, or bound to statin drugs, which are potent competitive inhibitors of HMGR activity and thus lower cholesterol levels in the blood \[[@B8],[@B9]\]. As reviewed in detail by Istvan \[[@B10]\], structural comparisons reveal both similarities and significant differences between the two classes of enzyme. The human HMGR has three major domains (catalytic, linker and anchor), whereas the *P. mevalonii*HMGR has only the catalytic domain (Figure [1](#F1){ref-type="fig"}).

Both HMGR~H~and HMGR~P~have a dimeric active site with residues contributed by each monomer, and a non-Rossman-type coenzyme-binding site (a three-dimensional structural fold that contains a nucleotide-binding motif and is found in many enzymes that use the dinucleotides NADH and NADPH for catalysis). The core regions containing the catalytic domains of the two enzymes have similar folds. Despite differences in amino-acid sequence and overall architecture, functionally similar residues participate in the binding of coenzyme A by the two enzymes, and the position and orientation of four key catalytic residues (glutamate, lysine, aspartate and histidine) is conserved in both classes of HMGR.

Unlike the central cores, the amino- and carboxy-terminal regions of the catalytic domains show little similarity between the human and *P. mevalonii*HMGR structures. The active site of HMG-CoA reductase is at the interface of the homodimer between one monomer that binds the nicotinamide dinucleotide and a second monomer that binds the HMG-CoA. In human HMGR, the catalytic lysine is found on the monomer that binds the HMG-CoA and comes from the so-called *cis*-loop (a section that connects the HMG-CoA-binding region with the NADPH-binding region). In contrast, the *P. mevalonii*HMGR lacks the *cis*-loop and the catalytic lysine is contributed by the monomer that binds the nicotinamide dinucleotide. HMGR~P~crystallizes as a trimer of dimers (which are composed of identical subunits), but HMGR~H~crystallizes as a tetramer (of identical units). HMGR~P~uses NADH as a coenzyme, whereas HMGR~H~uses NADPH, but mutation to alanine of the aspartyl residue of HMGR~P~that normally blocks binding of NADPH can allow NADPH to serve - albeit poorly - as the coenzyme for HMGR~P~. A 180° difference in the orientation of the nicotinamide ring of the coenzyme suggests that that the stereospecificity of the HMGR~H~hydrogen transfer is opposite to that of HMGR~P~.

Comparisons between the HMGR~P~and HMGR~H~structures reveal an overall similarity in how they bind statins, which inhibit activity by blocking access of HMG-CoA to the active site. There is a considerable difference in specific interactions with inhibitor between the two enzymes, however \[[@B8],[@B9]\], accounting for the almost 10^4^-fold higher *K*~*i*~values for inhibition of HMGR~P~by statin relative to the inhibition of HMGR~H~(*K*~*i*~ is the equilibrium constant for an inhibitor binding to an enzyme). There are significant differences in the regions of the two proteins that bind statins. In both enzymes the portion of the statin that resembles HMG (see Figure [3](#F3){ref-type="fig"}) occupies the HMG portion of the HMG-CoA-binding pocket, and the non-polar region partially occupies a portion of the coenzyme-A-binding site. For HMGR~P~, this impairs closure over the active site of the \'tail\' domain that contains the catalytic histidine.

Localization and function
=========================

HMGRs of eukaryotes are localized to the endoplasmic reticulum (ER), and are directed there by a short portion of the amino-terminal domain (prokaryotic HMGRs are soluble and cytoplasmic). In humans, the reaction catalyzed by HMGR is the rate-limiting step in the synthesis of cholesterol, which maintains membrane fluidity and serves as a precursor for steroid hormones. In plants, a cytosolic HMG-CoA reductase participates in the synthesis of sterols, which are involved in plant development, certain sesquiterpenes, which are important in plant defense mechanisms against herbivores, and ubiquinone, which is critical for cellular protein turnover. In plastids, however, these compounds are synthesized via a pathway that does not involve mevalonate or HMGR \[[@B1]\]. Various plant HMGR isozymes function in fruit ripening and in the response to environmental challenges such as attack by pathogens. In yeast, either of the two ER-anchored HMGR isozymes can provide the mevalonate needed for growth.

Enzyme mechanism
----------------

The reaction catalyzed by HMGR is:

(*S*)-HMG-CoA + 2 NADPH + 2 H^+^→ (*R*)-mevalonate + 2 NADP^+^+ CoA-SH.

with the (*S*)-HMG-CoA and (*R*)-mevalonate designations referring to the stereochemistry of the substrate and product (enzymatic reactions are stereospecific and the (*R*)-HMG-CoA isomer is not a substrate for HMGR). This three-stage reaction involves two reductive stages and the formation of enzyme-bound mevaldyl-CoA and mevaldehyde as probable intermediates:

Stage 1: HMG-CoA + NADPH + H^+^→ \[Mevaldyl-CoA\] + NADP^+^

Stage 2: \[Mevaldyl-CoA\] → \[Mevaldehyde\] + CoA-SH

Stage 3: \[Mevaldehyde\] + NADPH + H^+^→ Mevalonate + NADP^+^

Kinetic analysis of point mutants of HMGR~P~and of HMGR~H~, and inspection of the crystal structures of HMGR~P~and HMGR~H~, has identified an aspartate, a glutamate, a histidine, and a lysine that are likely to be important and have suggested their probable roles in catalysis (Figure [4](#F4){ref-type="fig"}) \[[@B11]\].

Regulation
----------

A highly regulated enzyme, HMGR~H~is subject to transcriptional, translational, and post-translational control \[[@B12]\] that can result in changes of over 200-fold in intracellular levels of the enzyme. The transcription factor sterol regulatory element-binding protein 2 (SREBP-2) participates in regulating levels of HMGR~H~mRNA in response to the level of sterols \[[@B13]\]; the regulatory process is as follows. At the ER membrane or the nuclear envelope, SREBP-2 binds to SREBP cleavage activating protein (SCAP) to form a SCAP-SREBP complex that functions as a sterol sensor. The proteins Insig-1 and Insig-2 bind to SCAP when cellular cholesterol levels are high and prevent movement of the SCAP-SREBP complex from the ER to the Golgi. In cells depleted of cholesterol, Insig-1 and Insig-2 allow activation of the SCAP-SREBP complex and its translocation to the Golgi, where SREBP is cleaved at two sites. Cleavage releases the amino-terminal basic helix-loop-helix (bHLH) domain, which enters the nucleus, where it functions as a transcription factor that recognizes non-palindromic decanucleotide sequences of DNA called sterol-regulatory elements (SREs). Binding of the bHLH domain of SREBP to an SRE promotes transcription of the *hmgr*gene.

Degradation of HMGR~H~involves its transmembrane regions \[[@B14]\]: removal of two or more transmembrane regions abolishes the acceleration of HMGR~H~degradation that occurs under certain conditions \[[@B12],[@B15]\]: degradation is induced by a non-sterol, mevalonate-derived metabolite alone or by a sterol plus a mevalonate-derived non-sterol metabolite, possibly farnesyl pyrophosphate or farnesol. Four conserved phenylalanines in the sixth membrane span of the transmembrane region are essential for degradation of HMGR~H~\[[@B16]\]. Insig-1 also functions in the degradation of HMGR~H~\[[@B17]\]: when cholesterol levels are high, SCAP and HMGR~H~compete for binding to Insig-1. If SCAP binds Insig-1, the SCAP-Insig-1 complex is retained in the Golgi, whereas if HMGR~H~binds Insig-1, HMGR~H~is ubiquinated on lysine 248 and is rapidly degraded through a ubiquitin-proteasome mechanism \[[@B18]\].

The catalytic activity of the HMGRs of higher eukaryotes is attenuated by phosphorylation of a single serine, which in the case of HMGR~H~is at position 872 \[[@B19]\]. The location of this serine - six residues from the catalytic histidine, a spacing conserved in all higher eukaryote HMGRs - suggests that the phosphoserine may interfere with the ability of this histidine to protonate the inhibitory CoAS^-^thioanion that is released in stage 2 of the reaction mechanism. Alternatively, it may interfere with closure of the flap domain, a carboxy-terminal region that is thought to close over the active site to facilitate catalysis, a step thought to be essential for formation of the active site \[[@B7]\]. Subsequent dephosphorylation restores full catalytic activity. HMGR kinase (also called AMP kinase) phosphorylates HMGR; the primary phosphatase *in vivo*is thought to be protein phosphatase 2A (PP2A), but both phosphatases 2A and 2B can catalyze dephosphorylation of vertebrate HMGR *in vitro*\[[@B20]\]. HMGR~H~activity therefore responds to hormonal control through AMP levels and PP2A activity. Phosphorylation of serine 577 of *A. thaliana*HMGR isozyme 1 by a plant HMGR kinase that does not require 5\'-AMP attenuates activity, and restoration of HMGR activity follows from dephosphorylation \[[@B21]\]. As many plant genes encode a putative target serine surrounded by an apparent AMP kinase recognition motif, it is probable that most plant HMGRs are regulated by phosphorylation. Yeast HMGR activity is, however, unaffected by AMP kinase. The phosphorylation state of HMGR does not affect the rate at which the protein is degraded.

Frontiers
=========

Several basic unresolved questions concern how phosphorylation controls the catalytic activity of HMGRs; solution of the structures of phosphorylated HMGRs should reveal more of the precise mechanism. The protein kinases, phosphatases, and signal-transduction pathways that participate in short-term regulation of HMGR activity are yet to be elucidated. Finally, the physiological roles served by the multiple ways in which HMGR is regulated require clarification. On the medical side, continuing intense competition between drug companies for a share of the lucrative worldwide market for hypercholesterolemic agents should result in new statin drugs with modified pharmacodynamic and metabolic properties that not only lower plasma cholesterol levels more effectively but more importantly minimize undesirable side effects.

Figures and Tables
==================

![Schematic representation of the human *hmgr*gene and the human HMGR~H~and *P. mevalonii*HMGR~P~proteins. **(a)**The exon-intron structure of the human *hmgr*gene, which extends from position 74717172 to position 74741998 of the human genome; positions refer to the Ensembl Transcript ID for the human *hmgr*gene (ENST00000287936 \[22\]). The numbers indicate the start and end of each exon and intron and refer to the position in the human genome sequence, omitting the first three digits (747); exons are indicated as filled boxes. Exon 1 is an untranslated region (UTR), as are the last 1,758 nucleotides of exon 20. The exons encoding the membrane-anchor domain, a flexible linker region, and the catalytic domain are indicated below the gene structure. **(b)**Human HMGR protein (HMGR~H~) is comprised of three domains: the membrane anchor domain, a linker domain, and a catalytic domain; within the catalytic domain subdomains have been defined. The N domain connects the L domain to the linker domain; the L domain contains an HMG-CoA binding region; and the S domain functions to bind NADP(H). The *cis*-loop (indicated by an asterisk), a region present only in HMGR~H~but not HMGR~P~, connects the HMG-CoA-binding region with the NADPH-binding region. **(c)**The HMGR~P~protein does not contain the membrane-anchor domain or the linker domain but has a catalytic domain containing a large domain with an HMG-CoA binding region, and a small, NAD(H)-binding domain. The active site of HMG-CoA reductase is present at the homodimer interface between one monomer that binds the nicotinamide dinucleotide and a second monomer that binds HMG-CoA. The numbers underneath the diagrams in (b,c) denote amino acids (in the single-letter amino-acid code) that are implicated in catalysis; S872 of HMGR~H~is reversibly phosphorylated. At the extreme carboxyl terminus of each enzyme is a flap domain (approximately 50 amino acids in HMGR~P~and 25-30 amino acids in HMGR~H~) that closes over the active site during catalysis; the flap domain is indicated by shading in (b,c).](gb-2004-5-11-248-1){#F1}

![A phylogenetic tree of HMGRs. The tree includes 98 selected organisms that have *hmgr*genes; for plants, which have multiple isoforms, only isoform 1 of each species is included in the tree. Roman numerals indicate the division of the family into two classes \[2,3\]. Phylogenetic analysis was performed using aligned amino-acid sequences of HMGR catalytic domains; membrane anchor domains were excluded from analysis. Amino-acid sequence alignments were generated using ClustalW \[23\] and the phylogenetic tree constructed with TreeTop \[24\] using the cluster algorithm with PHYLIP tree-type output. Full species names and GenBank accession numbers of the sequences used are provided in Table 1.](gb-2004-5-11-248-2){#F2}

![Structures of lovastatin, a statin drug that competitively inhibits HMGR, and of HMG-CoA. It can be seen that the portion of the drug shown here at the top resembles the HMG portion of HMG-CoA.](gb-2004-5-11-248-3){#F3}

![Proposed reaction mechanism for HMGR~P~\[7,18\]. The side groups of the key catalytic residues, Lys267, Asp283, Glu83, and His381, are shown, and the substrate and products are shown with R representing the HMG portion. The reaction follows three stages (see text for details). A basically similar mechanism has been proposed for HMGR~H~\[4\].](gb-2004-5-11-248-4){#F4}

###### 

Details of the sequences used for the phylogenetic tree in Figure 2

  **Organism name\***                            **Kingdom**   **Accession number**
  ---------------------------------------------- ------------- ----------------------
  *Mus musculus*(mouse)                          Eukaryote     XM_127496
  *Mesocricetus auratus*(hamster)                Eukaryote     X00494
  *Rattus norvegicus*(rat)                       Eukaryote     BC064654
  *Homo sapiens*(human)                          Eukaryote     NM_000859
  *Gallus gallus*(chicken)                       Eukaryote     AB109635
  *Xenopus laevis*(frog)                         Eukaryote     M29258
  *Drosophila melanogaster*(fruit fly)           Eukaryote     NM_206548
  *Homarus americanus*(lobster)                  Eukaryote     AY292877
  *Blatella germanica*(cockroach)                Eukaryote     X70034
  *Dendroctonus jeffreyi*(Jeffrey pine beetle)   Eukaryote     AF159136
  *Ips pini*(bark beetle)                        Eukaryote     AF304440
  *Ips paraconfusus*(bark beetle)                Eukaryote     AF071750
  *Raphanus sativus*(radish)                     Eukaryote     X68651
  *Arabidopsis thaliana*(thale-cress)            Eukaryote     NM_106299
  *Oryza sativa*(rice)                           Eukaryote     AF110382
  *Lycopersicon esculentum*(tomato)              Eukaryote     AAL16927
  *Nicotinia tabacum*(tobacco)                   Eukaryote     AF004232
  *Cucumis melo*(muskmelon)                      Eukaryote     AB021862
  *Hevea brasiliensis*(rubber tree)              Eukaryote     X54659
  *Pisum sativum*(pea)                           Eukaryote     AF303583
  *Solanum tuberosum*(potato)                    Eukaryote     L01400
  *Tagetes erecta*(African marigold)             Eukaryote     AF034760
  *Catharanthus roseus*(Madagascar periwinkle)   Eukaryote     M96068
  *Artemisia annua*(wormwood)                    Eukaryote     AF142473
  *Gossypium hirsutum*(cotton)                   Eukaryote     AF038046
  *Taxus × media*(yew)                           Eukaryote     AY277740
  *Andrographis paniculata*(Indian herb)         Eukaryote     AY254389
  *Malus × domestica*(apple)                     Eukaryote     AY043490
  *Capsicum annuum*(pepper)                      Eukaryote     AF110383
  *Camptotheca acuminata*                        Eukaryote     U72145
  *Saccharomyces cerevisiae*(baker\'s yeast)     Eukaryote     M22002
  *Schizosaccharomyces pombe*(fission yeast)     Eukaryote     CAB57937
  *Candida utilis*                               Eukaryote     AB012603
  *Trypanosoma cruzi*(trypanosome)               Eukaryote     L78791
  *Schistosoma mansoni*                          Eukaryote     M27294
  *Leishmania major*(trypanosome)                Eukaryote     AF155593
  *Dictyostelium discoideum*                     Eukaryote     L19349
  *Caenorhabditis elegans*                       Eukaryote     NM_066225
  *Strongylocentrotus purpuratus*(sea urchin)    Eukaryote     NM_214559
  *Dicentrarchus labrax*(European sea bass)      Eukaryote     AY424801
  *Penicillium citrinum*                         Eukaryote     AB072893
  *Ustilago maydis*                              Eukaryote     XM_400629
  *Eremothecium gossypii*                        Eukaryote     NM_210364
  *Gibberella zeae*                              Eukaryote     XM_389373
  *Gibberella fujikuroi*                         Eukaryote     X94307
  *Sphaceloma manihoticola*                      Eukaryote     X94308
  *Aspergillus nidulans*                         Eukaryote     EAA60025
  *Neurospora crassa*                            Eukaryote     XM_324891
  *Phycomyces blakesleeanus*                     Eukaryote     X58371
  *Archaeoglobus fulgidus*                       Archaea       NC_000917
  *Sulfolobus solfataricus*                      Archaea       U95360
  *Oceanobacillus iheyensis*                     Archaea       NC_004193
  *Thermoplasma volcanium*                       Archaea       BAB60335
  *Halobacterium sp*                             Archaea       AAG20075
  *Methanosarcina mazei*                         Archaea       AAM30031
  *Haloarcula hispanica*                         Archaea       AF123438
  *Thermoplasma acidophilum*                     Archaea       CAC11548
  *Picrophilus torridus*                         Archaea       AE017261
  *Archaeoglobus veneficus*                      Archaea       AJ299204
  *Ferroglobus placidus*                         Archaea       AJ299206
  *Archaeoglobus profundus*                      Archaea       AJ299205
  *Archaeoglobus lithotrophicus*                 Archaea       AJ299203
  *Haloferax volcanii*                           Archaea       M83531
  *Pyrococcus furiosus*                          Archaea       AAL81972
  *Pyrococcus abyssi*                            Archaea       AJ248284
  *Methanococcus maripaludis*                    Archaea       CAF29643
  *Methanocaldococcus jannaschii*                Archaea       AAB98699
  *Methanosarcina acetivorans*                   Archaea       AAM06446.
  *Methanopyrus kandleri*                        Archaea       AAM01570
  *Sulfolobus tokodaii*                          Archaea       AP000986
  *Aeropyrum pernix*                             Archaea       AP000062
  *Methanothermobacter thermautotrophicus*       Archaea       AAB85068
  *Pyrobaculum aerophilum*                       Archaea       AAL64009
  *Bdellovibrio bacteriovorus*                   Eubacteria    BX842650
  *Lactobacillus plantarum*                      Eubacteria    AL935253
  *Streptococcus agalactiae*                     Eubacteria    CAD47046
  *Lactococcus lactis*                           Eubacteria    AE006387
  *Vibrio cholerae*                              Eubacteria    AAF96622
  *Vibrio vulnificus*                            Eubacteria    AAO07090.
  *Vibrio parahaemolyticus*                      Eubacteria    BAC62311
  *Enterococcus faecalis*                        Eubacteria    AAO81155
  *Lactobacillus johnsonii*                      Eubacteria    AE017204
  *Chloroflexus aurantiacus*                     Eubacteria    AJ299212
  *Enterococcus faecium*                         Eubacteria    AF290094
  *Listeria monocytogenes*                       Eubacteria    AE017324
  *Listeria innocua*                             Eubacteria    CAC96053
  *Streptococcus pneumoniae*                     Eubacteria    AF290098
  *Staphylococcus epidermidis*                   Eubacteria    AF290090
  *Staphylococcus haemolyticus*                  Eubacteria    AF290088
  *Staphylococcus aureus*                        Eubacteria    AF290086
  *Streptomyces griseolosporeus*                 Eubacteria    AB037907
  *Streptomyces sp.*                             Eubacteria    AB015627
  *Streptococcus pyogenes*                       Eubacteria    AF290096
  *Streptococcus mutans*                         Eubacteria    AAN58647
  *Paracoccus zeaxanthinifaciens*                Eubacteria    AJ431696
  *Pseudomonas mevalonii*                        Eubacteria    M24015
  *Borrelia burgdorferi*                         Eubacteria    AE001169.
  *Actinoplanes sp.*                             Eubacteria    AB113568

\*Common names are indicated in parentheses Accession numbers for each sequence are available from sequence databases accessible through the National Center for Biotechnology Information \[25\].
